Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry

Sponsor
Lille University
Study ID
NCT06924463
Status
Recruiting
Apply to this trial

Conditions

  • Rhabdomyosarcoma

Eligibility Criteria

Sex
ALL
Age
0 Years - 25 Years
Healthy Volunteers
Not accepted

Interventions

  • None AHT — OTHER
    This study does not involve any interventions. It analyzes pre-existing biological samples (FFPE tumor tissue) and clinical data from patients with rhabdomyosarcoma.

Study Details

This non-interventional study aims to develop spatial proteomics for analyzing small FFPE tumor samples in rhabdomyosarcoma. It will identify molecular signatures linked to tumor regions, subtypes, survival, and treatment resistance, using pre-existing samples and data.

Key Dates

First listed
Apr 11, 2025
Start date
Mar 13, 2025
Status verified
Apr 2025
Primary completion
Dec 31, 2025
Completion
Feb 28, 2026

Study Design

Enrollment
20 participants (estimated)

Primary Outcome Measure

Spatial Proteomic Profiling of Tumor Samples [ Time Frame: 12 months (study duration) ]

Related Studies